

320
• Annual Report 2018-19
Shaping the future of software driven business
ESOP
Scheme
Particulars
Year Ended
Outstanding at
the beginning of
the Year
Granted
during the
Year
Forfeited
during the
Year
Exercised
during the
Year
Outstanding
at the end of
the Year
Exercisable at
the end of the
Year
Scheme X Number of Options March 31, 2019
461,351
-
31,124
274,577
155,650
155,650
Weighted Average
Price
March 31, 2019
201.74
-
204.64
204.64
206.73
206.73
Number of Options March 31, 2018
988,647
-
258,392
268,904
461,351
461,351
Weighted Average
Price
March 31, 2018
204.22
-
209.07
209.07
201.74
201.74
Scheme XI
Number of Options March 31, 2019
36,000
-
9,600
26,400
-
-
Weighted Average
Price
March 31, 2019
5.00
-
5.00
5.00
-
-
Number of Options March 31, 2018
402,600
-
323,400
43,200
36,000
36,000
Weighted Average
Price
March 31, 2018
10.00
-
10.00
10.00
10.00
10.00
Scheme XII
Number of Options March 31, 2019
-
-
-
-
-
-
Weighted Average
Price
March 31, 2019
-
-
-
-
-
-
Number of Options March 31, 2018
67,300
-
14,850
52,450
-
-
Weighted Average
Price
March 31, 2018
10.00
-
10.00
10.00
-
-
Total
Number of Options March 31, 2019
1,695,216
-
80,506
560,732
1,053,978
1,053,978
Number of Options March 31, 2018
2,872,614
-
629,831
547,567
1,695,216
1,695,216
The weighted average share price for the period over which stock options were exercised was
`
697.09 (previous year
`
690.36)
c) Details of exercise price for stock options outstanding at the end of the year
Scheme
Range of
exercise price
As at March 31, 2019
As at March 31, 2018
No. of Options
outstanding
Weighted average
remaining
contractual life
(in years)
No. of Options
outstanding
Weighted average
remaining
contractual life
(in years)
Scheme I
2.04 – 9.57
18
Note (i)
20
Note (i)
Scheme II
12.96 – 48.21
3
2.40
103
3.40
Scheme III
12.96 – 48.21
158,625
Note (i)
203,392
Note (i)
Scheme IV
22.23 – 61.12
499,773
3.93
708,946
4.92
Scheme V
22.23 – 44.14
62,793
Note (i)
96,856
Note (i)
Scheme VI
22.23 – 30.67
-
-
-
-
Scheme VII
24.17 – 61.12
34,996
3.37
37,996
4.56
Scheme VIII
48.21 – 48.21
-
-
-
-
Scheme IX
54.74 – 54.74
142,120
4.03
150,552
5.03
Scheme X
157.58 – 279.70
155,650
1.85
461,351
0.67
Scheme XI
10.00
-
-
36,000
0.25
Scheme XII
10.00
-
-
-
-
Note (i): No contractual life is defined in the scheme.
d) Effect of the employee share-based payment plans on the statement of profit and loss and on its financial position
Compensation expense arising from equity-settled employee share-based payment plans for the year ended March 31,
2019 amounted to Nil (Previous year
`
2.23 million). The liability for employee stock options outstanding as at March 31,
2019 is
`
76.29 million (Previous year
`
90.52 million).
Notes forming part of financial statements (Contd.)